Lauren S Holliday, MD | |
8 Richland Medical Park Dr, Suite 300, Columbia, SC 29203-8005 | |
(803) 256-6511 | |
(803) 744-4731 |
Full Name | Lauren S Holliday |
---|---|
Gender | Female |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 15 Years |
Location | 8 Richland Medical Park Dr, Columbia, South Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033348537 | NPI | - | NPPES |
318418 | Medicaid | SC |
Facility Name | Location | Facility Type |
---|---|---|
Prisma Health Richland Hospital | Columbia, SC | Hospital |
Newberry County Memorial Hospital | Newberry, SC | Hospital |
Prisma Health Baptist | Columbia, SC | Hospital |
Prisma Health Baptist Parkridge | Columbia, SC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Prisma Health Medical Group-midlands | 5991099707 | 865 |
News Archive
Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.
For the first time in the U.S., a clinical trial is underway that's evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.
VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.
The map, featured in BioMed Central's open access International Journal of Health Geographics, gives a county-level representation of the likelihood of dying as the result of natural events such as floods, earthquakes or extreme weather.
Can probiotics prevent pneumonia in patients breathing with the help of ventilators? That's just one question researchers at Washington University School of Medicine in St. Louis hope to answer as part of innovative new studies to reduce infections in health-care settings.
› Verified 3 days ago
Entity Name | Columbia Heart Clinic Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245266139 PECOS PAC ID: 3274439575 Enrollment ID: O20031209000158 |
News Archive
Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.
For the first time in the U.S., a clinical trial is underway that's evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.
VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.
The map, featured in BioMed Central's open access International Journal of Health Geographics, gives a county-level representation of the likelihood of dying as the result of natural events such as floods, earthquakes or extreme weather.
Can probiotics prevent pneumonia in patients breathing with the help of ventilators? That's just one question researchers at Washington University School of Medicine in St. Louis hope to answer as part of innovative new studies to reduce infections in health-care settings.
› Verified 3 days ago
Entity Name | Prisma Health Tuomey |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548625593 PECOS PAC ID: 2163728528 Enrollment ID: O20160310001016 |
News Archive
Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.
For the first time in the U.S., a clinical trial is underway that's evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.
VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.
The map, featured in BioMed Central's open access International Journal of Health Geographics, gives a county-level representation of the likelihood of dying as the result of natural events such as floods, earthquakes or extreme weather.
Can probiotics prevent pneumonia in patients breathing with the help of ventilators? That's just one question researchers at Washington University School of Medicine in St. Louis hope to answer as part of innovative new studies to reduce infections in health-care settings.
› Verified 3 days ago
Entity Name | Prisma Health Medical Group-midlands |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275988321 PECOS PAC ID: 5991099707 Enrollment ID: O20160802001226 |
News Archive
Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.
For the first time in the U.S., a clinical trial is underway that's evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.
VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.
The map, featured in BioMed Central's open access International Journal of Health Geographics, gives a county-level representation of the likelihood of dying as the result of natural events such as floods, earthquakes or extreme weather.
Can probiotics prevent pneumonia in patients breathing with the help of ventilators? That's just one question researchers at Washington University School of Medicine in St. Louis hope to answer as part of innovative new studies to reduce infections in health-care settings.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Lauren S Holliday, MD Po Box 743904, Atlanta, GA 30374-3904 Ph: (803) 296-7320 | Lauren S Holliday, MD 8 Richland Medical Park Dr, Suite 300, Columbia, SC 29203-8005 Ph: (803) 256-6511 |
News Archive
Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.
For the first time in the U.S., a clinical trial is underway that's evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.
VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.
The map, featured in BioMed Central's open access International Journal of Health Geographics, gives a county-level representation of the likelihood of dying as the result of natural events such as floods, earthquakes or extreme weather.
Can probiotics prevent pneumonia in patients breathing with the help of ventilators? That's just one question researchers at Washington University School of Medicine in St. Louis hope to answer as part of innovative new studies to reduce infections in health-care settings.
› Verified 3 days ago
William Cole Andrew, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 14 Richland Medical Park Dr Ste 320, Columbia, SC 29203 Phone: 803-434-8721 | |
Seetharamprasad Madala, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1801 Sunset Dr, Columbia, SC 29203 Phone: 803-434-4153 Fax: 803-434-4160 | |
Michael Martin, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2 Medical Park Rd, Columbia, SC 29203 Phone: 803-434-6956 | |
Dr. Terry A Grainger, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8 Richland Medical Park Dr Ste 100, Columbia, SC 29203 Phone: 803-434-3800 Fax: 803-744-2759 | |
Dr. Adelero Olayinka Adebajo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1520 Laurel St, Columbia, SC 29201 Phone: 803-799-8407 Fax: 803-252-9070 | |
Jeff Z Brooker Jr., MD, RETIRED Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1625 Bernardin Ave, Columbia, SC 29204 Phone: 803-251-8985 | |
Dr. Ronald L Collins, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1711 Saint Julian Pl, Columbia, SC 29204 Phone: 803-779-0911 Fax: 803-256-2480 |